InvestorsHub Logo
Followers 33
Posts 3510
Boards Moderated 0
Alias Born 11/17/2013

Re: beartrap12 post# 623408

Tuesday, 08/22/2023 6:06:55 PM

Tuesday, August 22, 2023 6:06:55 PM

Post# of 698806
Bear, here is what I posted back in May 2023 about BP or NWBO buying Oncovir:

hankmanhub
Re: meirluc post# 595498
Tuesday, May 23, 2023 10:57:18 PM
Top of Form
Post# of 623411 Go
Bottom of Form
I might voice a possible concern. As this thread seems to assume that Oncovir on its own is going nowhere with the patent due to expire shortly, but would be worth alot in the hands of NWBO as part of the dcvax platform. It seems to me that with LP seemingly demanding a top dollar from BP (whichever one) the thing to do for a BP is to acquire Oncovir at a multiple of its current value, but this would still be a dirt cheap entree to NWBO for a necessary ingredient for DCVAX. Right now would the time to do this as the BP could easily outbid NWBO in its bid for Oncovir at this time - this may not be true further down the road..

hankmanhub
Re: meirluc post# 595503
Tuesday, May 23, 2023 11:18:23 PM
Top of Form
Post# of 623411 Go
Bottom of Form
My point was not for BP to buy Oncovir for itself, but to use it as an entree to make a deal with LP and NWBO for something they (NWBO) may need more than just a large checkbook. This would be chips on the table which they can use to make a good deal with NWBO.

hankmanhub
Re: skitahoe post# 595504
Tuesday, May 23, 2023 11:24:14 PM
Top of Form
Post# of 623411 Go
Bottom of Form
Skit, I do not think what the owners of Oncovir are looking for is guaranteed continued employment. that is small potatoes. They will want a cut of the pie, and a seat at the table when Oncovir is taken over by BP (now) or by NWBO (later) to merge the DCVAX platform with iclc and thus also extend the patent that is near expiration.

hankmanhub
Re: meirluc post# 595514
Tuesday, May 23, 2023 11:50:53 PM
Top of Form
Post# of 623411 Go
Bottom of Form
While you are right, the cost of iclc after the patent expires will not be terribly high, but thejr lost opportunity costs of not owning Oncovir and being able to control iclc by extending its patent will be a significant bargaining chip and worth alot to NWBO. The whole (merged DCVAX and iclc) is much greater than the sum of its parts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News